Delivery Order SPE2DB22D1106-SPE2DB25FDVY3
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,240.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75mg capsules, a medication used for the treatment of influenza. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. It is not designated with any set-aside requirements, indicating open competition....
This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
The federal contract award, with ID SPE2DB20D7059|SPE2DB25FPXY7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.86 firm fixed-price delivery order contract is for the supply of 4566918317 units of Oseltamivir Phosphate 30 mg capsules. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support...
This federal contract award, valued at $1,238.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through December 2025. This single-award IDC serves as the primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,554.79 firm fixed-price delivery order contract is for the supply of 4,567,282,823 units of 30 mg Oseltamivir Phosphate capsules. The contract has a ceiling value of $3,554.79 and runs through February 18, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
The federal contract award with ID SPE2DB20D7059|SPE2DB24FQFD3 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,564,535,806 units of the pharmaceutical product Oseltamivir Phosphate 75 mg capsules. This is a Firm Fixed Price Delivery Order contract with a ceiling value of $2,716.76 and a performance period ending on May 9, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award, SPE2DB22D1106|SPE2DB24FDRT3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,129.40 firm fixed-price delivery order is for the supply of 4,563,157,638 units of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2022. Amerisourcebergen...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB25FK9TL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza. The award has a ceiling value of $2,497.20 and is a firm fixed-price delivery order contract, with a final completion date of January 29, 2025. The...
This federal contract award, valued at $1,317.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,562,181,703 units of Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite...